OrbiMed’s iTeos Therapeutics ITOS Stock Holding History

OrbiMed’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-700,000	Closed	-$6.98M	–	118
2025 Q2	$6.98M	Buy	+700,000	New	+$5.64M	0.17%	71

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

OrbiMed's ITOS Position: Q3 2025 in Review

OrbiMed sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 700,000 shares — an estimated $6.98M sold.

OrbiMed first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $6.98M in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

OrbiMed reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
OrbiMed sold 700,000 iTeos Therapeutics shares in Q3 2025, an estimated $6.98M.
OrbiMed first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
OrbiMed's iTeos Therapeutics position peaked at $6.98M in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on OrbiMed's 13F filing for Q3 2025, filed 14 Nov 2025.